Safe and Green Development (SGD) is excited to share its expected timeline for completion of its joint venture developments in Southern Texas. The timeline below is only considering the existing ...
DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (NASDAQ: LTRN), an artificial intelligence (AI) company dedicated to developing cancer therapies and transforming the cost, pace, and timeline of oncology ...
The US military takes too long to develop new technologies and turn them into effective battlefield platforms. That is the assessment of Deputy Secretary of Defense Kathleen Hicks, who on 31 August ...
Cambridge, MA – Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company today announced a set of preclinical drug discovery benchmarks ...
Hyderabad: Life sciences and medtech global capability centres (GCCs) in India are shifting from cost-focused delivery units ...
A key part of consultants’ work is the global harmonization of CMC guidelines. Differences in regulatory requirements across regions can lead to inefficiencies in the drug development process.
Dallas was working on cars at a Honda dealership rocking a MyTouch 4G when Artem and the gang started Android Police. It was this very website that got him into Android in the first place — he'd sneak ...
The report by KPMG in India and UnearthIQ highlighted how pharma and life sciences GCCs are leveraging AI to bring in measurable gains and lower drug development time.
Global harmonization of CMC guidelines is a key focus for top pharmaceutical consultants. Variations in regulatory requirements across regions often create inefficiencies in drug development—for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results